| scholarly article | Q13442814 |
| P50 | author | Amy C Justice | Q42395670 |
| Kristina Crothers | Q42768813 | ||
| P2093 | author name string | Kevan C Herold | |
| Matthew S Freiberg | |||
| David Rimland | |||
| Janet P Tate | |||
| Kathleen M Akgün | |||
| Maria C Rodriguez-Barradas | |||
| Adeel A Butt | |||
| Cynthia L Gibert | |||
| David A Leaf | |||
| Chris B Ruser | |||
| Melissa Herrin | |||
| P2860 | cites work | The role of HIV in serious diseases other than AIDS. | Q37186467 |
| Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. | Q37258157 | ||
| HIV infection and the risk of diabetes mellitus. | Q37365031 | ||
| The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care | Q38023235 | ||
| Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes | Q38209594 | ||
| Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study | Q38413429 | ||
| Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs. | Q42200366 | ||
| Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). | Q43437312 | ||
| Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus | Q43490122 | ||
| Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy | Q43512126 | ||
| A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors | Q43613003 | ||
| Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort | Q44530878 | ||
| Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women | Q44696436 | ||
| Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection | Q44967738 | ||
| Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors | Q45199391 | ||
| Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study | Q46505818 | ||
| A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. | Q46618919 | ||
| Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries | Q47192068 | ||
| Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. | Q47345030 | ||
| Changes in weight and lean body mass during highly active antiretroviral therapy | Q47403936 | ||
| Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. | Q51388029 | ||
| Development and verification of a "virtual" cohort using the National VA Health Information System. | Q51937405 | ||
| When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort | Q73523868 | ||
| Investigating heterogeneity in studies of resting energy expenditure in persons with HIV/AIDS: a meta-analysis | Q81498020 | ||
| Impact of obesity on cardiovascular disease | Q84797905 | ||
| Diagnosis and Classification of Diabetes Mellitus | Q22255454 | ||
| Increasing rates of obesity among HIV-infected persons during the HIV epidemic | Q28473706 | ||
| Type 2 diabetes as an inflammatory disease | Q29617184 | ||
| Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study | Q31146395 | ||
| Systemic effects of inflammation on health during chronic HIV infection | Q33577551 | ||
| Obesity among HIV-infected persons: impact of weight on CD4 cell count | Q33883870 | ||
| Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source | Q34017348 | ||
| Virologic and immunologic response to HAART, by age and regimen class | Q34137148 | ||
| Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study | Q34415980 | ||
| The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation | Q35030011 | ||
| Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapy | Q35930197 | ||
| Weight change after antiretroviral therapy and mortality | Q35974655 | ||
| Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetes | Q36346682 | ||
| Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering | Q36429076 | ||
| Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons | Q36634864 | ||
| The role of chronic inflammation in obesity-associated cancers | Q36931512 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | veteran | Q193891 |
| weight gain | Q3403879 | ||
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 228-236 | |
| P577 | publication date | 2016-10-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals | |
| P478 | volume | 73 |
| Q40296763 | Aging metabolism: intervention strategies |
| Q46442340 | Can Biomarkers Advance HIV Research and Care in the ART Era? |
| Q91536624 | HIV and cardiovascular disease |
| Q52613761 | HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy. |
| Q95730561 | Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy |
| Q52722319 | Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV. |
| Q89584749 | Metabolic Syndrome in HIV/HCV Co-infected Patients |
| Q89771713 | Obesity and Weight Gain in Persons with HIV |
| Q99238630 | Predictors of Change in Weight Among People Living with HIV on Antiretroviral Treatment in West Hararghe Zone, Ethiopia: A Retrospective Longitudinal Study |
| Q92543455 | Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006-2016 |
| Q99609907 | Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota |
| Q39025975 | Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health? |
| Q89688886 | T Lymphocyte Subsets Associated with Prevalent Diabetes in Veterans with and without HIV |
| Q59806829 | The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality |
| Q90673145 | Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials |
| Q40076712 | Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens |
| Q58812046 | Weight Gain: A Possible Side Effect of All Antiretrovirals |
| Q91957393 | Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada |
Search more.